Belgium· BE-AMP-SAM666145-00
Atenativ 1000 IU
A antithrombin iii product containing human antithrombin iii, registered in Belgium by Octapharma Benelux. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Antithrombin iii is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AB02 (antithrombin iii), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Antithrombin iii · ATC B01AB02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Human Antithrombin III
- Manufacturer
- Octapharma Benelux
- Country
- Belgium (BE)
- ATC code
- B01AB02
- ATC class
- Antithrombin III
- Defined daily dose
- 2.1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
112 interactions on record for antithrombin iii.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Antithrombin iii · interactions on record
112 records
- 41 severe
- 71 moderate
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Antithrombin iii in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainATENATIV 1000 UI, POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONOctapharma S.A.
- NorwayAtenativOctapharma AB
- CzechiaANBINEXInstituto Grifols, S.A., Barcelona
- PolandAnbinexInstituto Grifols S.A.
- SwitzerlandAtenativ 1000 I.E., Pulver und Lösungsmittel zur Herstellung einer InfusionslösungOctapharma AG
- GermanyAnbinexGrifols Deutschland Gmbh
- United KingdomAntithrombin III 1,000unit powder and solvent for solution for infusion vialsImported (Austria)
- NetherlandsAntitrombine III concentraat Baxalta 500 IE, poeder en oplosmiddel voor injectie of intraveneuze infusieBaxalta Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Antithrombin Iii Takeda, Atenativ
- Bulgaria · Антитромбин Iii Nf Получен От Човешка Плазма Баксалта, Атенатив
- Czechia · Anbinex, Antithrombin Iii Baxalta
- Germany · Anbinex, Atenativ
- Denmark · Antitrombin Iii Baxalta, Atenativ
- Estonia · Atenativ
- Spain · Anbinex, Kybernin P
- Finland · Atenativ
- France · Aclotine, Atenativ
- Greece · Kybernin P
- Croatia · Antithrombin Iii Baxalta, Atenativ
- Hungary · Antithrombin Iii Baxalta, Atenativ
- Italy · Anbinex, Anternaty
- Lithuania · Atenativ
- Luxembourg · Kybernin P
- Latvia · Atenativ
- Malta · Antithrombin Iii Baxalta
- Netherlands · Antitrombine Iii Concentraat Baxalta, Atenativ
- Norway · Atenativ
- Poland · Anbinex, Antithrombin Iii Nf Takeda
- Portugal · Anbinex, Atenativ
- Romania · Atenativ
- Sweden · Antithrombin Iii Baxalta, Antithrombin Iii Octapharma
- Slovenia · Atenativ, Kybernin P
- Slovakia · Anbinex, Antithrombin Iii Ľudský Antitrombín Iii Získaný Z Plazmy Baxalta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbf21615-9610-4f7f-a1a5-72e171d0c34b GET /v1/drugs/cbf21615-9610-4f7f-a1a5-72e171d0c34b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Atenativ 1000 IU",
"name_fr": "Atenativ 1000 IU",
"name_nl": "Atenativ 1000 IU",
"amp_code": "SAM666145-00",
"strengths": null,
"pack_count": 1,
"substances": [
"Human Antithrombin III",
"N-Acetyl Tryptophan Sodium",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Antithrombin III",
"authorisation_numbers": [
"BE666145"
]
}See everything about antithrombin iii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.